No Data
No Data
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device
Express News | Axonics Inc - Expects to Commence Sales of R20 to Australian Customers in November
Express News | Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable Snm System in Australia
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Deals This Week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and More
Piper Sandler Maintains Axonics(AXNX.US) With Hold Rating, Maintains Target Price $71
Piper Sandler analyst Adam Maeder maintains $Axonics(AXNX.US)$ with a hold rating, and maintains the target price at $71.According to TipRanks data, the analyst has a success rate of 60.1% and a